<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1409881/" ref="ordinalpos=4864&amp;ncbi_uid=704181&amp;link_uid=PMC1409881" image-link="/pmc/articles/PMC1409881/figure/f1-15/" class="imagepopup">Figure. From: Transforming Growth Factor-? Promotes Pro-fibrotic Behavior by Serosal Fibroblasts via PKC and ERK1/2 Mitogen Activated Protein Kinase Cell <span class="highlight" style="background-color:">Signaling</span>. </a></div><br /><div class="p4l_captionBody"><b>FIGURE 1.</b> TGF-Î² cell signaling via Smad proteins and ERK 1/2 MAP kinase pathways. The ERK 1/2 pathway is activated by phosphorylation in a PKC-dependent or -independent manner and signals to the nucleus where gene transcription is regulated. Go6850 is a broad spectrum PKC inhibitor, PD98059 inhibits MEK 1, while Uo126 inhibits both MEK 1 and 2 subtypes.</div></div>